Journal profile · Hematology
Annals of Hematology
ISSN 0939-5555 · eISSN 1432-0584 · Springer Berlin Heidelberg · GERMANY · Monthly · Founded 1955
Annals of Hematology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.3; fully open access; APC about USD 4,590; median 109 days to acceptance (89 articles, last 24 months); community-reported acceptance: about 66.66%; 568 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annals of Hematology is published by Springer Berlin Heidelberg and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research, together about 27.3% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
A forum for clinical hematology, hemostaseology, blood transfusion, and related aspects of medical oncology Also covers diagnosis and treatment of leukemias and lymphomas, and transplantation of hematopoietic stem cells including cellular therapy Examines relevant aspects of oncology, molecular biology and immunology Annals of Hematology covers the whole spectrum of clinical hematology, coagulation research and therapy, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias and lymphomas, transplantation of hematopoietic stem cells and cellular therapies of hematological disorders. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Massimo BrecciaPublisher website
Editorial board by country: 3 in mainland China (about 5%); most named Italy 17, Germany 13, Japan 4, Mainland China 3, Spain 3 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine10.5%
- Lymphoma Diagnosis and TreatmentMedicine9.7%
- Chronic Lymphocytic Leukemia ResearchMedicine7.1%
- Hematopoietic Stem Cell TransplantationMedicine6.2%
- Hemoglobinopathies and Related DisordersMedicine5.5%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5%
- Chronic Myeloid Leukemia TreatmentsMedicine4.8%
- Acute Lymphoblastic Leukemia researchMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.3LetPub ·
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.6Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 73LetPub ·
- h-index
- 114OpenAlex ·
- i10-index
- 5,023OpenAlex ·
- 2-year mean citedness
- 2.15OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 57.23%LetPub ·
Volume
- Articles per year
- 524LetPub ·
- Downloads per year (publisher) 2025
- 2,100,000Publisher website ·
Articles by year OpenAlex count · 13,812 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 536 | 536 | 170 |
| 2025 | 568 | 568 | 1,192 |
| 2024 | 557 | 211 | 2,205 |
| 2023 | 508 | 173 | 3,061 |
| 2022 | 349 | 114 | 2,908 |
| 2021 | 364 | 140 | 4,304 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
109 daysMedian, submission to acceptance · P25–P75 70 days – 150 days
- Acceptance to online
- median 16 days (89 articles)
- Submission to online
- median 127 days
- Sample
- 89 articles with submission and acceptance dates (560 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 66.66%LetPub ·
- Submission to first decision
- 9 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
- Myeloproliferative NeoplasmsDeadline
- Advancements in Multiple MyelomaDeadline
What to prepare7 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted13, with length limits
- brief reportAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…main text ≤ 2,000 words
- case reportAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- commentaryAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- correspondenceAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review proce…Length not stated
- letterAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- literature reviewAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- original researchAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- original research articleAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- research articleAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- reviewAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- review articleAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
- surveyAnnals of Hematology welcomes Research, Review, Brief Report, Case Report, Correspondence, and Matters Arising article types. Articles should be formatted accor…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Annals of Hematology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1955
- ISSN
- 0939-5555
- Electronic ISSN
- 1432-0584
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Annals of Hematology
What CAS zone is Annals of Hematology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Hematology is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annals of Hematology?
The latest impact factor listed by LetPub is 2.3; CiteScore 3.3, h-index 114.
How long does peer review take at Annals of Hematology?
Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 109 days (interquartile range 70–150 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 66.66%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Annals of Hematology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Templates: LaTeX; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Annals of Hematology based?
Of the 57 board members whose country the journal's board page names, 3 (about 5%) are in mainland China; the countries named most often are Italy (17), Germany (13) and Japan (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Annals of Hematology?
According to LetPub and DOAJ records, Annals of Hematology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Annals of Hematology open access, and what is the APC?
Annals of Hematology is a fully open-access journal. APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .